United States · FDA National Drug Code directory
POSACONAZOLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17856-2133_4fea6190-d259-a7e3-e063-6394a90aa93f
- Product NDC
- 17856-2133
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Posaconazole
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190828
- Source listing expiry
- 20271231
Source-listed ingredients
- POSACONAZOLE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 POUCH in 1 BOX, UNIT-DOSE (17856-2133-1) / 1 TABLET, DELAYED RELEASE in 1 POUCH (17856-2133-2) · 17856-2133-1
- 59 POUCH in 1 BOX (17856-2133-5) / 1 TABLET, DELAYED RELEASE in 1 POUCH · 17856-2133-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →